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Equilibrium fraction
Additional insights into the Ant-PIm-HSA binding process were provided by analyzing the equilibrium fraction (f u ) of the uncomplexed Ant-PIm which is an important pharmacokinetic parameter involved in drug elimination and distribution in the body and can be described by the following equation: As can be seen from Figure S1 , the equilibrium fraction f u was higher than 45% and increased linearly on increasing the Ant-PIm concentration which supports and anticipates the suitability of Ant-PIm to be used as a fluorescent sensor for HSA detection even at low concentration.
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Thermodynamic analysis of the Ant-PIm-HSA system
In order to provide further information on the intermolecular forces involved on the stabilization of the association process between HSA and Ant-PIm, its thermodynamic parameters were determined. Non-covalent forces that dominate ligands and biomacromolecules binding in aqueous solution include electrostatic and hydrophobic interactions, hydrogen bonds and van der Waals forces. If the enthalpy and entropy (ΔH, ΔS) associated to the binding event are assumed not to vary significantly along the temperature range studied, both enthalpy and entropic contribution (TΔS) can be estimated by using the van't Hoff equation:
As a result, the slope and the intercept of the linear plot between log K a and the reciprocal absolute temperature allowed us to establish the values of ΔH and ΔS, respectively ( Figure S2 ). Spontaneity of the process could be ascertained by the negative values systematically measured for ΔG (-26.2 ± 0.2, -27.1 ± 0.1 and -27.9 ± 0.1 kJ mol -1 at 298, 304 and 310 K, respectively).
S4
Besides, the positive values of both ΔH (14.7 ± 1.4 kJ mol -1 ) and ΔS (137.5 ± 12.1 J mol
indicate that the Ant-PIm-HSA complex is entropically driven, thus stabilized mainly by shortrange interactions even though long-range ionic forces mediated by the presence of the polycationic side chains certainly play a stabilizing role. These results can be explained considering the strong hydrophobic character of the anthracenyl derivative and its binding proximity to the hydrophobic binding compartment in which the tryptophan residue is located.
HSA binding pocket identification through site-marker competitive experiments
The HSA crystal structure analysis revealed that the main drug binding pockets are located within the hydrophobic cavities of the subdomains IIA and IIIA usually named Sudlow's sites 1 and 2, respectively. [4] [5] [6] Warfarin, an anticoagulant drug, is a stereotypical Sudlow's site 1 binder, whereas ibuprofen, a nonsteroidal anti-inflammatory agent, is a well-known Sudlow's site 2 binder. 7 To gain information about the Ant-PIm binding site, we monitored the changes in fluorescence of Ant-PIm bound to HSA (λ exc = 516 nm) upon increasing the site markers concentrations.
Unfortunately, no significant displacement of the anthracenyl derivative properties was observed, even at high drug concentrations (data not shown), probably due to the relatively high binding affinity of Ant-PIm to the serum protein and for its extended geometrical configuration which may cause steric hindrances for the insertion of the site markers into the multi-chamber cavity of the protein.
In order to stem this problem, we decided to reverse the approach and carry out further displacement studies, this time keeping constant the HSA-drugs (λ exc = 280 nm) concentration and
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increasing that of the fluorophore. As depicted in Figure S3 , the fluorescence of the HSA-drugs complexes was efficiently quenched by the addition of the Ant-PIm molecules strongly pointing to either a replacement or a co-binding of Ant-PIm onto the protein. Interestingly, the extent of replacing the well-known site markers was greater for ibuprofen than for warfarin. 
